NR
Narendra Rajdev Pandey
About Narendra Rajdev Pandey
Data last updated:
Narendra Rajdev Pandey is a Director at Decro Pharma Private Limited (since 2020). The company operates in Chemicals and Materials. Decro Pharma Private Limited reported revenue of ₹14.66 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Decro Pharma Private Limited U24210GJ2020PTC117562 | Director | 21 Oct 2020 | 2020 | ₹14.66 Cr (FY 2025) | Active |
Board colleagues of Narendra Rajdev Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvindbhai Patel | 09116796 | Decro Pharma Private Limited | Director |
| Bhikan Nimba Patil | 08929611 | Decro Pharma Private Limited | Director |
| Hareshbhai Kalabhai Patel | 08929612 | Decro Pharma Private Limited | Director |
| Rakesh Ambalal Patel | 03439091 | Decro Pharma Private Limited | Director |
| Sangitaben Rakeshkumar Patel | 03439056 | Decro Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narendra Rajdev Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narendra Rajdev Pandey
Narendra Rajdev Pandey currently holds 1 directorship: Decro Pharma Private Limited (Director, since 21 Oct 2020, revenue ₹14.66 Cr (FY 2025)).
Narendra Rajdev Pandey was first appointed on 21 Oct 2020 as Director at Decro Pharma Private Limited.
The current boards of Narendra Rajdev Pandey's companies include Arvindbhai Patel (Decro Pharma Private Limited), Bhikan Nimba Patil (Decro Pharma Private Limited), Hareshbhai Kalabhai Patel (Decro Pharma Private Limited), Rakesh Ambalal Patel (Decro Pharma Private Limited), Sangitaben Rakeshkumar Patel (Decro Pharma Private Limited).